InvestorsHub Logo

Freeparking100

09/14/20 4:01 PM

#282 RE: DewDiligence #280

Possible FDA has issue with a lack of diversity of trial population and this is a cleverly worded pr about a delay and need to expand diversity to meet EUA standards.

Johnny_C

09/15/20 8:31 AM

#283 RE: DewDiligence #280

Guess what, the CEO of PFE stated they are on track this weekend. Adding to the trial could be that PFE and BNTX want to agree to more territories.

Lift Off is coming! BTW, the trial can be stopped at any time.